ImmunityBio recently reported positive clinical data from its ANKTIVA (nogapendekin alfa inbakicept) program in non-small ...

GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.

Findings indicate that higher minimum wages are linked to reduced maternal hypertensive disorders, emphasizing the impact of ...

Updated statistics show that it’s more than economic strength, charitable giving and religiosity that stand out.

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...

The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...

As the Union Budget 2026 approaches, public capital expenditure is poised to once again take centre stage.

The idea of the midlife crisis took hold decades ago and never went away, despite a lack of scientific evidence. The latest data should finally settle the score.

FY 2025 Preliminary Unaudited Total Revenue of Approximately $510--511 Million Meets or Exceeds Prior Guidance Previously Provided FY 2025 Adjusted EBITDA (1) and Adjusted Net Income (2) Guidance ...

The president posted the jobs data on his Truth Social account on Thursday evening ahead of the official release Friday.

Youth marijuana use is stable amid the state legalization movement, despite prohibitionist claims to the contrary. Beyond ...